Several HCC-specific SNVs, particularly T53C, were associated with HCC in both HBV genotypes B and C. Patients with moderate or high viral load benefited from early antiviral therapy regardless of ALT levels which is consistent with the ATTENTION trial and our previous work [14, 15]. The gene discussed is GPT; the disease is hepatocellular carcinoma.